Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan®

Scott J. Cameron, Gregory Gerhardt, Michael Engelstad, Mark A. Young, Edward J. Norris, Lori J Sokoll

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate interference by the hemoglobin-based oxygen carrier Hemospan® on clinical laboratory assays. Design and methods: Interfering Hemospan concentrations were determined for general chemistry and cardiac marker analytes in pooled serum and the corresponding hemolysis index was calculated. Results: Hemospan did not interfere with 20 of 35 analytes. Hemospan produced a negative interference in serum creatinine, amylase, alkaline phosphatase, uric acid, and GGT assays and a positive interference in serum phosphate, LDH, iron, triglycerides, total protein, AST, cholesterol, magnesium, and albumin assays, and appeared to positively bias the serum cardiac troponin I (cTnI) assay only when cTnI is present in the sample. Conclusions: We present a report of assays affected by Hemospan and the threshold concentrations for interference. This study highlights the importance of interference studies in understanding the effects of hemoglobin-based oxygen carriers on results reported by the clinical laboratory.

Original languageEnglish (US)
Pages (from-to)221-224
Number of pages4
JournalClinical Biochemistry
Volume42
Issue number3
DOIs
StatePublished - Feb 2009

Fingerprint

Clinical Chemistry
Assays
Hemoglobins
Oxygen
Clinical laboratories
Troponin I
Serum
Amylases
Hemolysis
Uric Acid
Magnesium
Alkaline Phosphatase
Albumins
Creatinine
Triglycerides
Iron
Phosphates
Cholesterol
MP4 maleimide-polyethylene glycol-modified hemoglobin
Proteins

Keywords

  • Blood
  • Chemistry
  • Hemoglobin based oxygen carriers (HBOC)
  • Hemospan
  • Interference
  • Transfusion

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan®. / Cameron, Scott J.; Gerhardt, Gregory; Engelstad, Michael; Young, Mark A.; Norris, Edward J.; Sokoll, Lori J.

In: Clinical Biochemistry, Vol. 42, No. 3, 02.2009, p. 221-224.

Research output: Contribution to journalArticle

Cameron, Scott J. ; Gerhardt, Gregory ; Engelstad, Michael ; Young, Mark A. ; Norris, Edward J. ; Sokoll, Lori J. / Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan®. In: Clinical Biochemistry. 2009 ; Vol. 42, No. 3. pp. 221-224.
@article{75be1f6922744dfe9f5e3d82c55f2e43,
title = "Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan{\circledR}",
abstract = "Objective: To evaluate interference by the hemoglobin-based oxygen carrier Hemospan{\circledR} on clinical laboratory assays. Design and methods: Interfering Hemospan concentrations were determined for general chemistry and cardiac marker analytes in pooled serum and the corresponding hemolysis index was calculated. Results: Hemospan did not interfere with 20 of 35 analytes. Hemospan produced a negative interference in serum creatinine, amylase, alkaline phosphatase, uric acid, and GGT assays and a positive interference in serum phosphate, LDH, iron, triglycerides, total protein, AST, cholesterol, magnesium, and albumin assays, and appeared to positively bias the serum cardiac troponin I (cTnI) assay only when cTnI is present in the sample. Conclusions: We present a report of assays affected by Hemospan and the threshold concentrations for interference. This study highlights the importance of interference studies in understanding the effects of hemoglobin-based oxygen carriers on results reported by the clinical laboratory.",
keywords = "Blood, Chemistry, Hemoglobin based oxygen carriers (HBOC), Hemospan, Interference, Transfusion",
author = "Cameron, {Scott J.} and Gregory Gerhardt and Michael Engelstad and Young, {Mark A.} and Norris, {Edward J.} and Sokoll, {Lori J}",
year = "2009",
month = "2",
doi = "10.1016/j.clinbiochem.2008.10.023",
language = "English (US)",
volume = "42",
pages = "221--224",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Interference in clinical chemistry assays by the hemoglobin-based oxygen carrier, Hemospan®

AU - Cameron, Scott J.

AU - Gerhardt, Gregory

AU - Engelstad, Michael

AU - Young, Mark A.

AU - Norris, Edward J.

AU - Sokoll, Lori J

PY - 2009/2

Y1 - 2009/2

N2 - Objective: To evaluate interference by the hemoglobin-based oxygen carrier Hemospan® on clinical laboratory assays. Design and methods: Interfering Hemospan concentrations were determined for general chemistry and cardiac marker analytes in pooled serum and the corresponding hemolysis index was calculated. Results: Hemospan did not interfere with 20 of 35 analytes. Hemospan produced a negative interference in serum creatinine, amylase, alkaline phosphatase, uric acid, and GGT assays and a positive interference in serum phosphate, LDH, iron, triglycerides, total protein, AST, cholesterol, magnesium, and albumin assays, and appeared to positively bias the serum cardiac troponin I (cTnI) assay only when cTnI is present in the sample. Conclusions: We present a report of assays affected by Hemospan and the threshold concentrations for interference. This study highlights the importance of interference studies in understanding the effects of hemoglobin-based oxygen carriers on results reported by the clinical laboratory.

AB - Objective: To evaluate interference by the hemoglobin-based oxygen carrier Hemospan® on clinical laboratory assays. Design and methods: Interfering Hemospan concentrations were determined for general chemistry and cardiac marker analytes in pooled serum and the corresponding hemolysis index was calculated. Results: Hemospan did not interfere with 20 of 35 analytes. Hemospan produced a negative interference in serum creatinine, amylase, alkaline phosphatase, uric acid, and GGT assays and a positive interference in serum phosphate, LDH, iron, triglycerides, total protein, AST, cholesterol, magnesium, and albumin assays, and appeared to positively bias the serum cardiac troponin I (cTnI) assay only when cTnI is present in the sample. Conclusions: We present a report of assays affected by Hemospan and the threshold concentrations for interference. This study highlights the importance of interference studies in understanding the effects of hemoglobin-based oxygen carriers on results reported by the clinical laboratory.

KW - Blood

KW - Chemistry

KW - Hemoglobin based oxygen carriers (HBOC)

KW - Hemospan

KW - Interference

KW - Transfusion

UR - http://www.scopus.com/inward/record.url?scp=58349106010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349106010&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2008.10.023

DO - 10.1016/j.clinbiochem.2008.10.023

M3 - Article

VL - 42

SP - 221

EP - 224

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 3

ER -